Scripps Research study uses modified ‘killer cells’ to defeat lymphoma while sparing healthy cells
Scientists at Scripps Research in La Jolla have demonstrated a promising new strategy for treating lymphomas, a group of cancers that begin in infection-fighting cells of the immune system called lymphocytes.